Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission
by on Thursday, April 26th, 2012 | No Comments
Condition: Neuroblastoma in Remission
Intervention: Drug: DFMO
Sponsors: Van Andel Research Institute; Giselle Sholler; Cancer Prevention Pharmaceuticals, Inc.; University of Arizona; University of Hawaii Cancer Research Center; University of Vermont
Not yet recruiting – verified April 2012
Read more: Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission